EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)

Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization

Cara A Flynn, Hamish J C McAuley, Omer Elneima, Hnin W W Aung, Wadah Ibrahim, Thomas J C Ward, Michelle Bourne, Tracey D Thornton, Vijay Mistry, Hannah R Gilbert, Ghazala Waheed, Adam K A Wright und 5 weitere

NEJM Evidence · 27.05.2025 · 4 (6)

DOI: 10.1056/evidoa2500012 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 27.05.2025. Verfasst von Cara A Flynn und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Lung Health, National Institute for Health and Care Research Leicester Biomedical Research Centre, University Hospitals of Leicester NH…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedPulmonary Disease, Chronic ObstructiveHumansMaleFemaleDouble-Blind MethodAgedHospitalizationMiddle AgedPatient ReadmissionEosinophilsQuality of LifePhenotypeTreatment Outcome

Substanzen

Antibodies, Monoclonal, Humanizedmepolizumab

Autor:innen und Institutionen

  • Institute for Lung Health, National Institute for Health and Care Research Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust and University of Leicester, UK.
  • Leicester Clinical Trials Unit, College of Life Sciences, University of Leicester, UK.

Zitieren

APA

Flynn, C. A., McAuley, H. J. C., Elneima, O., Aung, H. W. W., Ibrahim, W., Ward, T. J. C., Bourne, M., Thornton, T. D., Mistry, V., Gilbert, H. R., Waheed, G., Wright, A. K. A., Evans, R. A., Steiner, M. C., Brookes, C. L., Brightling, C. E., & Greening, N. J. (2025). Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization. NEJM Evidence, 4(6). https://doi.org/10.1056/evidoa2500012

Vancouver

Flynn CA, McAuley HJC, Elneima O, Aung HWW, Ibrahim W, Ward TJC, et al. Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization. NEJM Evidence. 2025;4(6). doi:10.1056/evidoa2500012

BibTeX
@article{Flynn2025,
  author = {Flynn, Cara A and McAuley, Hamish J C and Elneima, Omer and Aung, Hnin W W and Ibrahim, Wadah and Ward, Thomas J C and Bourne, Michelle and Thornton, Tracey D and Mistry, Vijay and Gilbert, Hannah R and Waheed, Ghazala and Wright, Adam K A and Evans, Rachel A and Steiner, Michael C and Brookes, Cassandra L and Brightling, Christopher E and Greening, Neil J},
  title = {Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization},
  journal = {NEJM Evidence},
  year = {2025},
  volume = {4},
  number = {6},
  doi = {10.1056/evidoa2500012}
}
Kostenlos starten →